You are here:

NICE
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Allergies

Pharmalgen for the treatment of bee and wasp venom allergy

Technology appraisal guidance
Reference number: TA246
Published: 22 February 2012

Guidance
Tools and resources
Information for the public
Evidence
History

Download guidance (PDF)

Overview
1 Guidance
2 Clinical need and practice
3 The technologies
4 Evidence and interpretation
5 Implementation
6 Related NICE guidance
7 Review of guidance
Appendix A: Appraisal Committee members and NICE project team
Appendix B: Sources of evidence considered by the Committee
Changes after publication
About this guidance

6 Related NICE guidance

Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode. NICE clinical guideline 134 (2011).

Next page 7 Review of guidance Previous page 5 Implementation